✦ LIBER ✦

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

✍ Scribed by Baptist Gallwitz; Julio Rosenstock; Thomas Rauch; Sudipta Bhattacharya; Sanjay Patel; Maximilian von Eynatten; Klaus A Dugi; Hans-Juergen Woerle

Book ID: 117310274
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 289 KB
Volume: 380
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(12)60691-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of treatment with si

Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial

✍ R. Arechavaleta; T. Seck; Y. Chen; K. J. Krobot; E. A. O’Neill; L. Duran; K. D. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 594 KB

Efficacy and safety of the dipeptidyl pe

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial

✍ M. A. Nauck; G. Meininger; D. Sheng; L. Terranella; P. P. Stein; Sitagliptin Stu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Efficacy and safety of initial combinati

Efficacy and safety of initial combination therapy with linagliptin and pioglitazone in patients with inadequately controlled type 2 diabetes: a randomized, double-blind, placebo-controlled study

✍ R. Gomis; R.-M. Espadero; R. Jones; H. J. Woerle; K. A. Dugi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 849 KB

Safety and efficacy of treatment with si

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study

✍ T. Seck; M. Nauck; D. Sheng; S. Sunga; M. J. Davies; P. P. Stein; K. D. Kaufman; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 378 KB

Fifty-two-week efficacy and safety of vi

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy

✍ E. Ferrannini; V. Fonseca; B. Zinman; D. Matthews; B. Ahrén; S. Byiers; Q. Shao; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Safety and efficacy of linagliptin as ad

Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study

✍ M.-R. Taskinen; J. Rosenstock; I. Tamminen; R. Kubiak; S. Patel; K. A. Dugi; H.- 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 797 KB